Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I understand that. In the short term, if you can make money elsewhere....why not ? But the money that can be made here dwarfs anything available anywhere else, imo.
I was being sarcastic...and also I was wrong. Hopefully, that investment will pay off the house in a couple years.
Don't worry; I put in a limit buy order at 0.999. We will not be below $1.00 again.
Expect GREAT news before Friday. That's when the brokerage will finally allow me to utilize the money I sent last week. Murphy's Law.
Sorry, my math was wrong. $6,500 / 0.66 = about 10 K shares
I hope to buy 15 K shares of CYDY in my IRA next January. But it won't be that many
Interesting company, but will the IPO have the slam dunk already priced in ? Whenever there's a company I'd like to buy at an IPO, it is exorbitant. Hopefully not with this one.
The lack of volume speaks volumes, doesn't it ? As if to say, "Cyto... what ?" Isn't that the biggest message the street is sending ?
Ok, Yahoo still says 6K, but stock charts says 171K. Thanks
Volume is less than 1,000 after lunch ??? Anonymityville Horror !
They put out a PR on the 21st. The FDA has I believe 60 days to respond to that. Approval is considered likely.
Volume is lower than ever it seems
3,600 shares traded, and it's almost lunch time ? We need to uplist !
There's no way to fill a 100 K order on most Friday's !
Wow, another zero Volume Friday for CYDY. It will take an INFINITE number of days with zero volume to reach $2 / share.
Levi and Korinski starts class action against JUNO therapeutics. Expect one against CYDY soon from these oysters. Hmm, Auto-correct doesn't like Yiddish words.
Vote NO on extension of reverse split, and vote NO on increase of authorized shares.
Economics and governmental policies DO AFFECT the publics participation rate in the markets.
I agree, vote no on extension
If getting up listed was such a high priority, it would have happened last year. I think they WANT to remain anonymous for now; I don't know why.
In last weeks conference call, Nader said that he wanted to present at the Croya conference. Does anyone have a link, and how do you spell that ?
The Feb timeline
Doctor Rx is one of the most read and respected people covering bios / pharma on SA. I've got to wonder about the value of reading almost anything now. Dismissing near zero vial load with zero side effects by using a near tautology ? How mindless can you get ? Or, is he lying ? Or does he have a blind spot, so to speak ? I can't yet imagine a scenario where I can find him trustworthy. He's very knowledgable, but should I spend my time listening to what he has to say ?
In general, I am placing dramatically less in almost all media. In so many places the people who OUGHT to know what they're talking about can be SO WRONG !
On Seeking Alpha, this is so true "I really am here just for the comments"
I've made comments on at least 5 GILD Seeking Alpha articles, and I have yet to get any sort of response from the author with an average 1 response from other readers.
Really ?... Then give specifics and not FUD.
Responded to a Seeeking Alpha article by DoctoRx aggressively mentioning how CYDY will affect Gild HIV revenues. Dr Rx has responded to virtually everyone else but me. I doubt anyone else will notice.
Some say insurance won't cover pro140. Side effects profile will encourage acceptance.
$20 Bill becomes $35 Bill !! Ok, minus a percentage for the X4 tropism.
HIV market will grow with PRO140. Why ? When people find out there is a treatment with no side effects, EVERYBODY will take their meds, not 56%. (Double check that figure)
Just beautiful, TooTall !
That is the new proposed upper limit of shares, yes. To be voted on soon.
Nader hinted that acute therapy could get to market first. Did you catch that ?
Patients...and patience.
Why doesn't big pharma just pay up early for a very promising drug / biological ? Just wondering. Perhaps they don't want the risk of a half or $1 B going down the drain ?
Who cares about next week ? We don't.
WHAAT ? They already have 200 patients in combo HIV trial ? They only need 150 !! That means the last patient could already be started !?!?!
No. Timelines moved forward, new acute market opening up, acute m might be first to market, enrollment for HIV sped up, means CYDY going up for a few days. How much and how long ... who knows?
And with 3 employees, CYDY will not be quick to update.
Then why oh why doesn't CYDY do the trial that FDA wanted ? Nader doesn't think it's worth the time. I disagree, but it ain't my company.